Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
12.35
-0.15 (-1.20%)
Jan 22, 2026, 2:51 PM EST
Eupraxia Pharmaceuticals Employees
Eupraxia Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees increased by 4 or 13.79% compared to the previous year.
Employees
33
Change (1Y)
4
Growth (1Y)
13.79%
Revenue / Employee
n/a
Profits / Employee
-1.34M CAD
Market Cap
633.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 33 | 4 | 13.79% | 33 | 0 |
| Dec 31, 2023 | 29 | 8 | 38.10% | 29 | 0 |
| Dec 31, 2022 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2021 | 21 | 9 | 75.00% | 19 | 2 |
| Dec 31, 2019 | 12 | 0 | - | 12 | 0 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bright Minds Biosciences | 26 |
| Medicenna Therapeutics | 18 |
| Satellos Bioscience | 17 |
| BriaCell Therapeutics | 16 |
| Sernova Biotherapeutics | 8 |
| NervGen Pharma | 7 |
| Helix BioPharma | 7 |